Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
plasma
Pharma
Record plasma collections spark a revenue boost for CSL
With plasma collections up 31% and to a record level, CSL reported revenue of $13.3 billion for fiscal year 2023, which was an increase of 26%.
Kevin Dunleavy
Aug 16, 2023 11:32am
New CEO Paul McKenzie plots CSL's course for growth
Apr 3, 2023 9:25am
Takeda pledges some $765M for plasma-derived therapy plant in Japan
Mar 23, 2023 5:09pm
Grifols is the latest drugmaker to succumb to the layoff trend
Feb 15, 2023 5:56pm
Takeda helps launch global educational push for plasma
Oct 10, 2022 11:21am
CSL to buy Vifor in biopharma's largest M&A deal this year
Dec 14, 2021 9:09am
